Conpany held a concall with investors, a very interesting one. The following are the highlights
- Liquid assets stands at 1540cr as on 30.6.23 of which 830cr are cash
- New line added for Softgel has just started realizing revenues
- Company is planing to enter Chile market through warehouse model and have already identified 90 products for the market that can be catered
- Caplin Sterile after a long wait for 4+ yrs have finally got USFDA approval
- Phase 2 expansion of the company will be completed by Oct’23 and company plans to move all terminal sterile products there
- The new state-of-the-art machinery will increase production multifold
- Caplin Onco – Tablets and injectables will be ready in 6 months
- After completion of all planned capex in next 2 yrs, Caplin will be vertically integrated and a name to be reckon with
- Plans to enter regulated markets are on and progressing well
- Planing to enter US markets with their own lable and trying to wliminate the frontend partners to realize better margins
- Expecting a much better H2 as the phase 2 completion will add more value
- Caplin revenues for the year 2016 are <= the Q1FY24 which is comandable growth
- Have entered new markets like Turkmenistan, laos, Chile
- Have done 200cr revenue yearly basis from Caplin steriles and planning to double it after phase 2 completion
Here are the important points i noted, if i missed anything from the concall plz share in the forum
| Subscribe To Our Free Newsletter |
